Patient-Centered Outcomes in Heart Failure Pharmacotherapy
IV iron and GLP1 agonists or GLP1/GIP agonists improved both QOL and exercise capacity in patients with HF. SGLT2 inhibitors significantly improved QOL but had no significant effect on exercise capacity.
Authors
- Maya Guglin (ORCID: https://orcid.org/0000-0001-5746-3135)
- Kazuhiko Kido (ORCID: https://orcid.org/0000-0002-3393-8025)
- Masayuki Hashiguchi
Institutions
- Jikei University School of Medicine (JP)
- West Virginia University (US)
- Johnson University (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.jacadv.2025.102356
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00